Global In Vitro Fertilisation (IVF) Market - Forecasts from 2019 to 2024
The global In Vitro Fertilisation (IVF) market is expected to grow at a CAGR of 11.24% during the forecast period to reach a total market size of US$40.348 billion by 2024, increasing from US$21.3 billion in 2018. In vitro fertilization (IVF) involves a complex series of procedures used to treat fertility or genetic problems and assist with the conception of a child. IVF is used to treat infertility patients with Blocked or damaged fallopian tubes, male factor infertility, women with ovulation disorders, premature ovarian failure, uterine fibroids, and removed fallopian tubes and unexplained infertility.
The global IVF services market is anticipated to exhibit significant market growth during the forecast period. The growth may be attributed to the rising male and female infertility rates due to the changing lifestyle. Growing awareness and acceptance about the infertility treatment will also bolster the adoption of the In Vitro Fertilization (IVF) techniques, thus boosting the growth of the In Vitro Fertilization (IVF) market. The increasing success rate of the IVF treatments will also augment the growth of the IVF market. However, high cost of the treatment coupled with the risk associated with the In-vitro Fertilization treatment might hamper the growth of the market during the given time frame.
The Global In Vitro Fertilisation (IVF) market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by cycle type, end-user, and geography.
Based on cycle type, the market has been segmented as Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles. On the basis of end-user the market is divided as fertility clinics, hospitals and research centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the market players.
Major players in the In Vitro Fertilisation (IVF) market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the In Vitro Fertilisation (IVF) market.
Segmentation:
The global IVF services market is anticipated to exhibit significant market growth during the forecast period. The growth may be attributed to the rising male and female infertility rates due to the changing lifestyle. Growing awareness and acceptance about the infertility treatment will also bolster the adoption of the In Vitro Fertilization (IVF) techniques, thus boosting the growth of the In Vitro Fertilization (IVF) market. The increasing success rate of the IVF treatments will also augment the growth of the IVF market. However, high cost of the treatment coupled with the risk associated with the In-vitro Fertilization treatment might hamper the growth of the market during the given time frame.
The Global In Vitro Fertilisation (IVF) market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by cycle type, end-user, and geography.
Based on cycle type, the market has been segmented as Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles. On the basis of end-user the market is divided as fertility clinics, hospitals and research centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the market players.
Major players in the In Vitro Fertilisation (IVF) market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the In Vitro Fertilisation (IVF) market.
Segmentation:
- By Cycle Type
- Fresh IVF Cycle
- Thawed IVF Cycle
- Donor Egg IVF Cycles
- By End-User
- Fertility clinics
- Hospitals and research centers
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- Italy
- Spain
- Others
- Middle East and Africa (MEA)
- Israel
- Saudi Arabia
- Others
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODO LOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. IN VITRO FERTILISATION (IVF) MARKET BY CYCLETYPE
5.1. Fresh IVF Cycle
5.2. Thawed IVF Cycle
5.3. Donor Egg IVF Cycles
6. IN VITRO FERTILISATION (IVF) MARKET BY INDICATION
6.1. Fertility clinics
6.2. Hospitals and research centers
7. IN VITRO FERTILISATION (IVF) MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. UK
7.3.2. Germany
7.3.3. Italy
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Israel
7.4.2. Saudi Arabia
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. Australia
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. COMPANY PROFILES
9.1. Cooper Surgical
9.2. Vitrolife AB
9.3. Thermo Fisher Scientific Inc.
9.4. Cook Medical
9.5. Irvine Scientific
9.6. Nikon Instruments Inc.
9.7. EMD Sereno
9.8. Genea Limited
9.9. IVFtech ApS
9.10. Hamilton Thorne, Inc.
List of Figures
List of Tables
Disclaimer
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODO LOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. IN VITRO FERTILISATION (IVF) MARKET BY CYCLETYPE
5.1. Fresh IVF Cycle
5.2. Thawed IVF Cycle
5.3. Donor Egg IVF Cycles
6. IN VITRO FERTILISATION (IVF) MARKET BY INDICATION
6.1. Fertility clinics
6.2. Hospitals and research centers
7. IN VITRO FERTILISATION (IVF) MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. UK
7.3.2. Germany
7.3.3. Italy
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Israel
7.4.2. Saudi Arabia
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. Australia
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. COMPANY PROFILES
9.1. Cooper Surgical
9.2. Vitrolife AB
9.3. Thermo Fisher Scientific Inc.
9.4. Cook Medical
9.5. Irvine Scientific
9.6. Nikon Instruments Inc.
9.7. EMD Sereno
9.8. Genea Limited
9.9. IVFtech ApS
9.10. Hamilton Thorne, Inc.
List of Figures
List of Tables
Disclaimer
